Literature DB >> 18711008

Characterization and functional analyses of the human G protein-coupled receptor kinase 4 gene promoter.

Sandra Hasenkamp1, Ralph Telgmann, Jan A Staessen, Claudia Hagedorn, Corinna Dördelmann, Martin Bek, Stefan-Martin Brand-Herrmann, Eva Brand.   

Abstract

The G protein-coupled receptor kinase 4 is involved in renal sodium handling and blood pressure regulation. Missense variants have already been tested functionally and are associated with hypertension, but no data on promoter analyses are yet available. We scanned 94 hypertensive white subjects for genetic variation and performed promoter reporter gene analyses in HEK293T, COS7, and SaOs-2 cells. Transient transfections with various full lengths and wild-type deletion constructs revealed that 1851 bp of the flanking region and 275 bp of the 5'-untranslated region were sufficient for transcriptional activities and composed a powerful cis-active element in the distal 293 bp. The -1702T and +2T alleles resulted in drastic general reductions of promoter function, whereas an activity increasing effect of +268C was cell type specific. Electrophoretic mobility-shift assay, supershift, and cotransfection analyses of transcription factor binding sites predicted in silico (Alibaba2.1/Transfac7) resulted in allele-specific binding patterns of nuclear proteins and identified the participation of CCAAT/enhancer-binding protein transcription factor family members. The G protein-coupled receptor kinase 4 core promoter resides in the first 1851 bp upstream of its transcription start site. The 4 identified genetic variants within this region exert allele-specific impact on both cell type- and stimulation-dependent transcription and may affect the expression balance of renal G protein-coupled receptor kinase 4.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18711008     DOI: 10.1161/HYPERTENSIONAHA.108.114512

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Dopamine receptors: important antihypertensive counterbalance against hypertensive factors.

Authors:  Chunyu Zeng; Pedro A Jose
Journal:  Hypertension       Date:  2010-11-22       Impact factor: 10.190

Review 2.  Primary Pediatric Hypertension: Current Understanding and Emerging Concepts.

Authors:  Andrew C Tiu; Michael D Bishop; Laureano D Asico; Pedro A Jose; Van Anthony M Villar
Journal:  Curr Hypertens Rep       Date:  2017-09       Impact factor: 5.369

3.  Evolutionary and functional analyses of cytochrome P4501A promoter polymorphisms in natural populations.

Authors:  Larissa M Williams; Marjorie F Oleksiak
Journal:  Mol Ecol       Date:  2011-11-18       Impact factor: 6.185

4.  HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling.

Authors:  John J Gildea; Ishan Shah; Ryan Weiss; Nicholas D Casscells; Helen E McGrath; Jin Zhang; John E Jones; Robin A Felder
Journal:  Hypertension       Date:  2010-07-26       Impact factor: 10.190

5.  Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.

Authors:  Ken Chen; Chunjiang Fu; Caiyu Chen; Li Liu; Hongmei Ren; Yu Han; Jian Yang; Duofen He; Lin Zhou; Zhiwei Yang; Lianfeng Zhang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2013-11-11       Impact factor: 10.190

6.  A novel role for c-Myc in G protein-coupled receptor kinase 4 (GRK4) transcriptional regulation in human kidney proximal tubule cells.

Authors:  John J Gildea; Hanh T Tran; Robert E Van Sciver; Dora Bigler Wang; Julia M Carlson; Robin A Felder
Journal:  Hypertension       Date:  2013-03-18       Impact factor: 10.190

7.  Promoting regulatory gene variation in sodium reabsorption.

Authors:  Peter A Doris
Journal:  Hypertension       Date:  2008-08-18       Impact factor: 10.190

Review 8.  G Protein-Coupled Receptor Kinases: Crucial Regulators of Blood Pressure.

Authors:  Jian Yang; Van Anthony M Villar; Ines Armando; Pedro A Jose; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2016-07-07       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.